Abstract
Background and Aim
Central giant cell tumour (CGCT) accounts for < 7% of all benign tumours of the jaws with various non-surgical and surgical treatment modalities. In this study, the authors perform one of the largest retrospective analysis on central giant cell tumour over a ten-year period.
Material and Methods
A total of 157 cases of CGCT treated in service hospitals by a single operator were retrospectively analysed in terms of basic demographic data, clinical and radiographic features, surgical intervention protocols, reconstruction modalities and complications.
Results
Out of the 157 patients, 70 were male and 87 were female with 97 cases (62%) localised to the maxilla and 60 cases (38%) localised to the mandible. Sixty-three patients presented with facial asymmetry whilst paraesthesia was noted in 20 patients. Radiographically, 105 lesions were multilocular (66%), whereas 52 were unilocular (33%). Out of the 97 maxillary CGCT, subtotal maxillectomy was performed in 60 cases and total maxillectomy without orbital exenteration in 37 cases. Radial forearm free flap reconstruction was done in 65 cases, fibula free flap was done in 15 cases, deep circumflex iliac artery free flap was done in 7 cases and patient-specific implant reconstruction was done in 10 cases. Out of the 60 mandibular CGCT, en block marginal resection was done in 37 cases, segmental resection was done in 13 cases and hemimandibulectomy was done in 10 cases. Fibula free flap was used as the reconstructive option in 20 cases, reconstruction plate was used in 25 cases and patient-specific implant reconstruction was done in 15 cases. Partial flap necrosis was noted in 5 patients (3%) and wound dehiscence in 8 patients (5%) and was managed conservatively.
Conclusion
Proper diagnosis and treatment planning is paramount for successful management of central giant cell tumour of the maxillofacial skeleton. In the present study, aggressive resection keeping a 5-mm safety margin was the preferred treatment modality with the reconstruction options ranging from autogenous options like radial forearm, fibula free flap and deep circumflex iliac artery free flap to alloplastic options like reconstruction plates and more recently patient-specific implants (PSIs). Though PSIs with their immediate functional and dental rehabilitation along with decreased patient morbidity mark an exciting and accessible alternate treatment modality with can revolutionise how we treat CGCT, long-term randomised controlled trials comparing autogenous reconstruction and patient-specific implants are needed before PSIs can be considered the primary reconstructive option.
Similar content being viewed by others
References
Austin LT, Dahlin CD, Royer RQ (1959) Giant cell reparative granuloma and related conditions affecting the jawbones. Oral Surg Oral Med Oral Pathol 12:1285–1295
Barnes L, Eveson JW, Reichart P, Sidransky D (2005) Pathology and genetics of head and neck tumors. In: Kleihues P, Sobin LH (eds) World Health Organization classification of tumors. IARC Press, Lyon, France
de Lange J, van den Akker HP, van den Berg H, Richel DJ, Gortzak RA (2006) Limited regression of central giant cell granuloma by interferon alpha after failed calcitonin therapy: a report of 2 cases. Int J Oral Maxillofac Surg 35(9):865–869
Pogrel MA (2003) Calcitonin therapy for central giant cell granuloma. J Oral Maxillofac Surg 61(6):649–653
Carlos R, Sedano HO (2002) Intralesional corticosteroids as an alternative treatment for central giant cell granuloma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 93(2):161–166
Rachmiel A, Emodi O, Sabo E, Aizenbud D, Peled M (2012) Combined treatment of aggressive central giant cell granuloma in the lower jaw. J Craniomaxillofac Surg 40(3):292–297
Tosco P, Tanteri G, Iaquinta C, Fasolis M, Roccia F, Berrone S, Garzino-Demo P (2009) Surgical treatment and reconstruction for central giant cell granuloma of the jaws: a review of 18 cases. J Cranio-Maxillofac Surg 37(7):380–387
Lima BC, Pinheiro GL, Pinto LAPF, Cavalcante MAA (2021) Treatment of a central giant cell lesion in the mandible. Natl J Maxillofac Surg 12(3):414–417
Chuong R, Kaban LB (1985) Diagnosis and treatment of jaw tumors in children. J Oral Maxillofac Surg 43(5):323–332
Chuong R, Kaban LB, Kozakewich H, Perez-Atayde A (1986) Central giant cell lesions of the jaws: a clinicopathologic study. J Oral Maxillofac Surg 44(9):708–713
Jaffe HL (1953) Giant-cell reparative granuloma, traumatic bone cyst, and fibrous (fibro-osseous) dysplasia of the jawbones. Oral Surg Oral Med Oral Pathol 6(1):159–175
Whitaker SB, Waldron CA (1993) Central giant cell lesions of the jaws: a clinical, radiologic, and histopathologic study. Oral Surg Oral Med Oral Pathol 75(2):199–208
Waldron CA, Shafer WG (1966) The central giant cell reparative granuloma of the jaws: an analysis of 38 cases. Am J Clin Pathol 45(4):437–447
Waldron CA, Shafer WG (1966) The central giant cell reparative granuloma of the jaws. Am J Clin Pathol 45:437–447
Eisenbud L, Stern M, Rothberg M, Sachs SA (1988) Central giant cell granuloma of the jaws: experiences in the management of thirty-seven cases. J Oral Maxillofac Surg 46(5):376–384
Kruse-Losler B, Diallo R, Gaertner C (2006) Central giant cell granuloma of the jaws: a clinical, radiologic, and histopathologic study of 26 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 101:346–354
Jacoway JR, Howell FV, Terry BC (1988) Central giant cell granuloma-dan alternative to surgical therapy. Oral Surg Oral Med Oral Pathol 66:572
Harris M (1993) Central giant cell granulomas of the jaws regress with calcitonin therapy. Br J Oral Maxillofac Surg 31(2):89–94
Chowdhury SKR, Padha K, Kumar R et al (2023) Scope of PSI in Maxillofacial Region: Our Experience. J Maxillofac Oral Surg 22(Suppl 1):124–132
Chowdhury SK, Padha K, Kumar R, Santra S (2022) Three patient specific implant designs with integrated dental implant components for reconstruction of mandibulectomy defects. Adv Oral Maxillofac Surg 1(8):100351
Padha K, Dhawan A, Duggal P, Kakkar V, Bhullar R, Kaur T (2022) PMMC flaps for reconstruction of oral defects in the age of microvascular flaps: A developing nation perspective. J Oral Biol Craniofac Res 12(6):743–747
Funding
No funds, grants or other support was received.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors have no conflicts of interest to declare that are relevant to the content of this article.
Ethical Approval
All procedures performed were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Informed Consent
Informed consent was obtained from the individuals included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Chowdhury, S.K.R., Padha, K., Singh, S. et al. Central Giant Cell Tumour of the Maxillofacial Region: A 10-Year Retrospective Analysis. J. Maxillofac. Oral Surg. (2024). https://doi.org/10.1007/s12663-023-02082-4
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s12663-023-02082-4